Image of enovis Logo

Enovis Expands Foot & Ankle Portfolio’s DynaClip® Family by Introducing Procedure-Specific Staples

Wilmington, DE, Jan. 17, 2023 (GLOBE NEWSWIRE) — Today, Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced the launch of the DynaClip Delta and DynaClip Quattro bone staples, the latest additions to the Company’s growing foot and ankle portfolio and the DynaClip® family of bone fixation systems.

Image of skeleton foot and ankle
Enovis Expands Foot Ankle Portfolios DynaClip® Family by Introducing Procedure Specific Staples

Designed to give foot and ankle surgeons ease of use and procedural efficiency in the operating room, the DynaClip Delta and DynaClip Quattro staples are pre-loaded on disposable inserters that facilitate quick deployment and accurate leg positioning. In addition, the DynaClip Delta staples are designed to deliver faster and easier first metatarsophalangeal (MTP) fusion procedures without compromising on durability and performance. New data shows that the DynaClip Delta Bone Fixation System has the stiffness of a traditional plate and lag screw construct, and the dynamic aspect of the staple greatly reduces permanent gapping.1

“I am a believer and user of NiTiNOL implants. The DynaClip Quattro NiTiNOL staple is a newly designed four-legged staple advancing the current design of NiTiNOL staples on the market,” said Tyler Gonzalez, MD, MBA, a Foot & Ankle Surgeon in Lexington, South Carolina. “Using this newly designed four-legged staple has added a new tool to my armamentarium for surgical fixation. It has improved my efficiency and expanded my versatility in midfoot and hindfoot fusions.”

Both DynaClip Delta and DynaClip Quattro use proven NiTiNOL technology to achieve sustained dynamic compression across fusion sites. Unlike traditional NiTiNOL staples that provide bone compression through the staple legs, DynaClip Delta and DynaClip Quattro staples are designed to distribute stress across the staple bridge.

“Providing surgeons with cutting-edge solutions that improve both efficiency and outcomes for our customers and patients is the ’why’ behind everything we do,” said Gary Justak, President and General Manager of Enovis Foot & Ankle. “Our customers have come to expect innovative, game-changing products from Enovis Foot & Ankle, and the introduction of the DynaClip Delta and Quattro staples is just another way that we are disrupting the market and elevating patient treatment options.”

For more information on the DynaClip Delta and DynaClip Quattro, please visit the following links:

  1. Data on File.

ABOUT ENOVIS

Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.

Contact:

Megan Foltz
Enovis
(609) 680-0996
Megan.Foltz@enovis.com

Dr. Gonzalez is a paid consultant of Enovis.

MK-10296

SOURCE: Enovis, January 17 2023.

To get your orthopaedic or spine congress, conference or event listed here, please email mkt@orthocg.com. Head to our dedicated marketing page for more information on our services.